Mobilização articular de tornozelo promove efeito neuroimunomodulatório em modelo de dor inflamatória em camundongos

Detalhes bibliográficos
Ano de defesa: 2020
Autor(a) principal: Omura, Carlos Minoru
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Não Informado pela instituição
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://repositorio.animaeducacao.com.br/handle/ANIMA/15154
Resumo: Introduction: This study aims to investigate the effects of ankle joint mobilization (AJM) on mechanical hyperalgesia and peripheral and central inflammatory biomarkers after intraplantar (i.pl.) Complete Freund's Adjuvant (CFA)-induced inflammation. Methodology: Male Swiss mice were randomly assigned to 3 groups (n = 7): Saline/Sham, CFA/Sham, and CFA/AJM. Five AJM sessions were carried out at 6, 24, 48, 72, and 96 hours after the model induction. The von Frey test was used to assess mechanical hyperalgesia. To investigate the immunomodulatory mechanisms at the inflammation site and the central modulation underlying the analgesic effects of AJM, the paw skin and muscle and spinal cord were collected to measure pro-inflammatory (TNF, IL-1β) and anti-inflammatory cytokines (IL-4, IL-10, and TGF-β1) by ELISA 98 hours after CFA injection. The macrophage phenotype at the inflammation site was evaluated using the NOS 2 (M1) and Arginase-1 (M2) immunocontent in the Western blotting assay. Results: Our results confirm a consistent analgesic effect of AJM following the second treatment. AJM did not change cytokines levels at the inflammation site, although it promoted a reduction in M2 macrophages. However, there was a reduction in the levels of pro-inflammatory cytokines IL-1β and TNF in the spinal cord. Taken together, the results confirm the anti-hyperalgesic effect of AJM and suggest a central neuroimmunomodulatory effect in a model of persistent inflammation targeting the pro-inflammatory cytokines IL-1β and TNF. Conclusion: These findings support that AJM can improve pain-induced inflammatory pathologies and modify the underlying pathological process.